New tool aims to ease breast cancer surgery decisions

NCT ID NCT07497256

Not yet recruiting Symptom relief Sponsor: Xiamen University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a decision aid called BCT Aid for women newly diagnosed with breast cancer. The tool helps patients understand their surgical options and what matters most to them. Researchers will compare women who use the aid to those who get usual care, looking at decision conflict, regret, and quality of life over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: decision aid (BCT Aid)
What this could lead to: If it works, this could help women with breast cancer feel more confident and satisfied with their surgical choice, and possibly improve their quality of life.
What could go wrong: This is a small, early-stage trial with 160 participants, so results may not apply to everyone. The decision aid is a behavioral tool, not a treatment, so it won't affect the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER COST-EFFECTIVENESS DECISION AID QUALITY OF LIFE SHARED DECISION MAKING

Contacts and locations

Locations

The First Affiliated Hospital of Xiamen University

Xiamen, Fujian, 361003, China
Women and Children's Hospital Affiliated to Xiamen University

Xiamen, Fujian, 361003, China
Xiang'an Hospital Affiliated to Xiamen University

Xiamen, Fujian, 361102, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.